cms_WV: 10671

In collaboration with The Seattle Times, Big Local News is providing full-text nursing home deficiencies from Centers for Medicare & Medicaid Services (CMS). These files contain the full narrative details of each nursing home deficiency cited regulators. The files include deficiencies from Standard Surveys (routine inspections) and from Complaint Surveys. Complete data begins January 2011 (although some earlier inspections do show up). Individual states are provides as CSV files. A very large (4.5GB) national file is also provided as a zipped archive. New data will be updated on a monthly basis. For additional documentation, please see the README.

This data as json, copyable

rowid facility_name facility_id address city state zip inspection_date deficiency_tag scope_severity complaint standard eventid inspection_text filedate
10671 CRESTVIEW MANOR NURSING & REHABILITATION 515160 P.O. BOX 967 JANE LEW WV 26378 2010-10-04 329 D 0 1 K6RU11 **NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** . Based on medical record review and review of the drug insert for [MEDICATION NAME] found on the Food and Drug Administration (FDA) website (www.fda.gov), the facility failed to assure the medication regimen of one (1) of twenty-seven (27) Stage II sample residents free from drugs for which the resident had a known allergy. Resident identifier: #12. Facility census: 68. Findings include: a) Resident #12 Review of Resident #12's medical record found that [MEDICATION NAME] was documented on the resident's list of known allergies [REDACTED]. The medical record contained documentation to reflect the resident had been ordered and received [MEDICATION NAME] 250 mg twice-a-day (BID). Review of the manufacturer's information for [MEDICATION NAME], found on the FDA's website, revealed [MEDICATION NAME] is metabolized by the body into [MEDICATION NAME] and Phenylethylmalonamide (PEMA). Under "Contraindications", the manufacturer stated: "... [MEDICATION NAME] is contraindicated in... 2) patients who are hypersensitive to [MEDICATION NAME]." The physician was notified on the afternoon of 09/30/10, and ordered the [MEDICATION NAME] tapered and discontinued. . 2015-01-01